The CELLSEARCH ® CTC Test is a simple, actionable blood test that helps oncologists assess the prognosis of patients with metastatic breast, prostate*, or colorectal cancer. The first and only clinically validated, FDA-cleared blood test for enumerating circulating tumor cells (CTCs).

Learn about FDA-cleared CELLSEARCH® Circulating Tumor Cell (CTC) Test for determining the prognosis of patients with metastatic breast, prostate, or colorectal cancer

2022年12月20日 · The CELLSEARCH ® CTC Test is an objective indicator of circulating tumor cell counts. The first and only actionable test for detecting CTCs in cancer patients with metastatic breast, prostate* or colorectal cancer. For in vitro diagnostic use.

Circulating tumor cell tests look for proteins or cells that break away from a breast cancer tumor and enter the bloodstream. The amount of circulating tumor cells (CTCs) in your blood can …

2021年2月4日 · A circulating tumor cell (CTC) test is a blood test that looks for tumor cells that were shed from a tumor and are now moving (circulating) through the bloodstream. Currently, CellSearch is the only FDA-approved CTC test for metastatic breast cancer.

Testing for circulating tumor DNA (ctDNA) examines a patient’s blood to detect DNA fragments from cancer cells enabling the identification of minimal residual disease through testing. RareCyte’s liquid biopsy platform integrates blood collection through imaging and single cell retrieval. Chaffer CL, Weinberg RA.

Biomarker testing – ctDNA is genetic material used for next-generation sequencing (NGS) to determine the status of a wide range of other biomarkers. CTC testing is whole cells that can have select biomarkers detected on or in the cell.

The OncoDiscover® CTC Test is India's first indigenously developed, patented in-vitro diagnostic test to get DCG (I) approval for marketing in India. This test is a highly specific and sensitive test that can detect, capture and enumerate Circulating Tumor Cells in very low volume of blood.

2024年11月25日 · Circulating Tumor Cells (CTCs) are cancer cells that detach from a primary tumor and enter the bloodstream, either as single cells or clusters. Detecting and analyzing these cells can provide critical insights into cancer progression and treatment planning. 1. Test Sensitivity and Specificity. 2. Real-World Accuracy vs. Spiked Sampling. 3.

Circulating Tumor Cell (CTC) testing represents a groundbreaking advancement in cancer diagnostics and monitoring. These tests provide valuable information that helps in the early detection and monitoring of cancer cells at the individual level, opening the door to truly personalized cancer care. What is CTC testing?